Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Lithium Ion SCHEMBL31015808 | 0.89 | ALDH1A1 (0.31) | ALDH1A1 | |
| Lithium Ion SCHEMBL1997799 | 0.89 | ALDH1A1 (0.31) | ALDH1A1 | |
| SCHEMBL16758706 | 0.89 | CA1 (0.33) | ALDH1A1 | |
| Potassium Ion SCHEMBL1466551 | 0.89 | ALDH1A1 (0.31) | ALDH1A1 | |
| SCHEMBL15212303 | 0.77 | TSHR (0.40) | — | |
| Tetramethylammonium Ion SCHEMBL1995405 | 0.77 | CHRNB2 (0.33) | — | |
| SCHEMBL1996407 | 0.71 | — | — | |
| SCHEMBL898869 | 0.56 | — | — | |
| Water SCHEMBL1325168 | 0.47 | — | — | |
| Water SCHEMBL1498163 | 0.47 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2279172-B1 | USE OF IONIC LIQUIDS WITH TETRACYANOBORATE ANIONS AS A SOLVENT FOR EXTRACTION OF ALCOHOLS FROM AQUEOUS SOLUTIONS | MERCK PATENT GMBH (DE) | 2013-06-26 | — | — | EP | disclosed |
| US-8455703-B2 | Use of ionic liquids with tetracyanoborate anions as a solvents for extraction of alcohols from aqueous solutions | MERCK PATENT GMBH (DE) | 2013-06-04 | — | — | US | disclosed |
| US-20110071324-A1 | Use of ionic liquids with tetracyanoborate anions as a solvents for extraction of alcohols from aqueous solutions | MERCK PATENT GESELLSCHAFT (DE) | 2011-03-24 | — | — | US | disclosed |
| EP-2279172-A2 | USE OF IONIC LIQUIDS WITH TETRACYANOBORATE ANIONS AS A SOLVENT FOR EXTRACTION OF ALCOHOLS FROM AQUEOUS SOLUTIONS | Merck Patent GmbH (DE) | 2011-02-02 | — | — | EP | disclosed |
| WO-2009152906-A2 | USE OF IONIC LIQUIDS WITH TETRACYANOBORATE ANIONS AS A SOLVENT FOR EXTRACTION OF ALCOHOLS FROM AQUEOUS SOLUTIONS | MERCK PATENT GMBH (DE) | 2009-12-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110071324-A1 | Use of ionic liquids with tetracyanoborate anions as a solvents for extraction of alcohols from aqueous solutions | ADH1C, SLC6A6, ADH5 | ALDH1A1 1093/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.